• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Nov. 30, 2025, 5:49 AM ESTBy Freddie ClaytonIsraeli attacks in Gaza have killed more than 70,000 people in over two years of war, according to the Palestinian Health Ministry, as the death toll continues to climb despite the ongoing ceasefire.Israel’s offensive in Gaza has killed at least 70,100 people since Hamas attacked Israel on Oct. 7 2023, which equates to more than 3% of the 2.3 million people living in the enclave. A further 170,983 people have been wounded.The World Health Organization has said that the numbers given by health officials in Gaza are reputable.A ceasefire between Israel and Hamas in Gaza remains in effect but has been tested by repeated outbreaks of violence, as Gaza’s residents face hunger, flooding and the onset of a bitter winter.Israeli fire killed two Palestinian children in the southern Gaza Strip on Saturday. The two brothers, aged 11 and 8, died when an Israeli drone struck close to a school sheltering displaced people in the town of Beni Suhaila, according to staff at Nasser Hospital, which received the bodies. The Israeli military said it killed two people who crossed into an Israeli-controlled area, “conducted suspicious activities” and approached troops. The statement didn’t mention children.Israeli strike on Gaza leaves 24 Palestinians dead, dozens wounded00:27Sunday’s grim milestone arrives more than two years after Hamas launched multipronged surprise attacks on Israel that left 1,200 people dead, with 240 people taken hostage by Hamas and other affiliated militant groups.An estimated 90% of Gaza’s population has been displaced since Oct. 7 2023, and more than 1.5 million people “urgently require emergency shelter assistance,” the United Nations’ migration agency IOM said last month.Walid Qabalan, a 53-year-old man, now lives with his family of nine in a small tent in the Al-Mawasi area west of Khan Younis. On the second day of the war, Walid, his wife, and their children were forced to flee their home in the city of Abasan, east of Khan Younis, after their home became too dangerous to reach.His daughter Amira, who is 13 and should be in eighth grade, instead spends her daily life keeping the family safe.“My days are spent making dough, waiting at the charity kitchen line, fetching water,” she told NBC News.Eleven-year-old Abrar, who should be in fifth grade, left school from the very first day of the war.They took our childhood,” she said. “Our playtime is gone, our home is gone, our memories are gone.”President Donald Trump’s Gaza peace plan was endorsed by a majority vote at the United Nations earlier this month, though world powers were still divided over whether it can convert the fragile ceasefire into the long-term solution that has eluded the Middle East.Designed to usher Gaza from rubble-strewn war zone into a new era, Trump’s plan would establish a “Board of Peace” to temporarily govern the territory and an International Stabilization Force taking over responsibility for maintaining the peace from the Israel Defense Forces currently occupying parts of the Gaza Strip.The proposal would be “phase two” of Trump’s 20-point plan first announced in September, “phase one” of which brought a prisoner and hostage exchange.Freddie ClaytonFreddie Clayton is a freelance journalist based in London. 

admin - Latest News - November 30, 2025
admin
3 views 16 secs 0 Comments




Israeli attacks in Gaza have killed more than 70,000 people in over two years of war, according to the Palestinian Health Ministry, as the death toll continues to climb.



Source link

TAGS:
PREVIOUS
Multiple people dead, several others injured in California shooting
NEXT
Nov. 30, 2025, 6:00 AM ESTBy David CoxIn early 2023, Liana Shatova began taking low doses of an antidepressant to ease symptoms of a premenstrual disorder marked by mood swings, anxiety and depression. At first, the difference was remarkable for her. “I felt full of energy and could juggle multiple things at once,” said Shatova, 40, a business development manager from the Greater Boston area. Then, after around 18 months on the medication, she started to fear she was becoming emotionally numb.“My best friend’s mom died unexpectedly, everyone was in shock and sobbing, and I couldn’t cry at all,” said Shatova. “I just felt nothing.” When Shatova asked her doctor if she could stop taking the medication sertraline, an antidepressant better known by its brand name Zoloft, she said she was reassured that she was on the lowest prescribed dose and that coming off it wouldn’t be difficult.Initially all seemed well, but after a month, Shatova said she experienced her first bout of what would become chronic insomnia, followed by panic attacks. Other symptoms emerged, including night sweats, muscle and joint pain and mood swings that left her unable to work. She said her doctor told her that the symptoms were a relapse of her premenstrual dysphoric disorder, and suggested a different antidepressant. Shatova declined the new drug.Antidepressants, primarily SSRIs, or selective serotonin reuptake inhibitors, are some of the most widely prescribed medications in the United States, taken by tens of millions of adults. About twice as many women as men report using an antidepressant in the past 30 days, with antidepressant use highest among women aged 60 and older, according to government data.Side effects are a key reason people choose to go off their medication, but stopping the drugs can also lead to withdrawal symptoms, research indicates. Along with the growing awareness, a deprescribing movement is building up in the field of psychiatry, aimed at helping patients reduce or stop their medications when no longer considered necessary. In a recent large analysis published in The Lancet in November, researchers at King’s College London found that physical side effects, including quick weight gain, significantly increased heart rate or elevated blood pressure, may be more common than once thought, depending on the drug. The review analyzed results from 151 clinical trials and 17 reports from the Food and Drug Administration, involving about 30 different prescription drugs used to treat depression, anxiety, and bipolar and panic disorders. The researchers examined the effects of antidepressants on weight, blood glucose, total cholesterol, blood pressure and heart rate. They didn’t look at emotional changes experienced by patients such as Shatova, although the lead study author said it should be examined further in future studies. “Not all antidepressants are built the same when it comes to their physical health side effects,” said Dr. Toby Pillinger, an academic clinical lecturer at King’s College London, who led the study. “Up until recently, we’ve approached antidepressant prescribing with a one-size-fits-all policy, and I think we need to move away from that.”Separately, in August, psychiatry researchers in the U.K. found that serious withdrawal effects may be more common than previously suspected, especially with longer-term use, although the study was small with just 18% of participants responding to the survey. The results showed that among people who had been taking antidepressants for more than two years, 63% reported moderate or severe withdrawal effects, with a third describing withdrawal issues that lasted more than three months. Symptoms ranged from insomnia to confusion, electric sensations, muscle cramps, agitation, mood swings and derealisation or an alteration in the person’s perception of the world. Dr. Mark Horowitz, a clinical research fellow at University College London who led the withdrawal study, said other research has found that roughly a quarter of patients experience severe symptoms when they abruptly stop taking their medications, from burning pain in the skin or limbs, balance problems, ongoing panic attacks, and sound and light sensitivity. Abrupt cessation of antidepressants is not recommended, but research has found that withdrawal symptoms can occur even when people attempt to taper. A review of various existing studies published last year by a group of German psychiatrists concluded that as many as 1 in 3 antidepressant users will experience some kind of withdrawal symptoms, with severe symptoms occurring in 1 in 30 users. Dr. Joseph Goldberg, clinical professor of psychiatry at the Icahn School of Medicine at Mount Sinai in New York, said that antidepressants have long been known to cause “discontinuation symptoms,” mainly nausea and dizziness, particularly if stopped abruptly.It’s unclear why some patients have severe symptoms after stopping their medications. Some researchers, concerned by reports of antidepressant withdrawal, suggest that the underlying mechanisms are similar to those faced by people suffering from alcohol and opiate withdrawal. “Withdrawal symptoms tell you that your brain is trying to restore a balance that it was forced to change by the presence of a drug,” said David Cohen, professor of social welfare at the University of California Los Angeles. “I think it’s the best accepted explanation for why stopping any centrally active drug, whether its antidepressants, coffee or heroin, leads to some discomfort.”The challenge for psychiatrists is that the drugs, which are often prescribed along with therapy, do help many people, particularly in the short term. Dr. Jonathan Alpert, a psychiatry professor at Albert Einstein College of Medicine, said that anecdotes of extreme withdrawal do not reflect his own professional experience. In his practice, Alpert estimated that two-thirds of his patients have been on antidepressants for more than five years, and only a small handful had experienced protracted withdrawal symptoms lasting more than a few days.“There’s been this very inflated idea that it’s really difficult to come off psychiatric medications,” said Alpert. “Even though I respect people’s narratives of their own experience, it feels very different from what we see in clinical practice and research studies.”Goldberg also expressed skepticism as to whether antidepressants themselves are actually responsible for the symptoms being reported by patients. “If somebody, after years of treatment, develops some frankly rather peculiar and unexpected neurological problems, I’m not sure how confident one can attribute that to medicine,” he said. “Anything is possible. But I think we have to consider the more likely possibility that the thing they’re encountering may be unrelated.” More than a year after Shatova first attempted to taper off the medication, she said she’s still undergoing a painstaking process of tiny, gradual reductions to try to avoid exacerbating her symptoms. “I am still tapering and now at 0.835 mg of Zoloft, doing it very slowly and carefully,” she said. “My sleep has gotten better, but I still have windows and waves triggered by life stresses and hormonal fluctuations.” It’s important not to dismiss people’s experiences, Goldberg said, and anyone going through symptoms should undergo further testing. A past president of American Society of Clinical Psychopharmacology, Goldberg said that the organization is now completing new guidelines on deprescribing. The goal is to help doctors explain what to expect when stopping psychiatric medications so patients don’t self-taper without medical supervision.Alpert suggested analyzing different types of data stored in electronic health records to get insight into the characteristics of patients who have prolonged withdrawal symptoms. “Do they have abnormal MRIs or blood tests with inflammatory markers? Through looking at large datasets, it will be more possible to identify predictors of this subset of people who seem to have unusually prolonged symptoms.”Cohen feels that the field of psychiatry needs to speed up research. However, in the wake of the 43% cut to the National Institutes of Health annual budget proposed to Congress by the current administration, a figure which is equivalent to $20 billion per year, it is likely that such studies would need to be carried out by either U.K. or European researchers. “We need large, nonindustry funded trials to examine what happens when people stop antidepressants, using various tapering strategies and long enough follow-up,” Cohen said. “We need dozens of such trials now.”If you or someone you know is in crisis, call or text 988, or go to 988lifeline.org, to reach the Suicide & Crisis Lifeline. You can also call the network, previously known as the National Suicide Prevention Lifeline, at 800-273-8255, or visit SpeakingOfSuicide.com/resources.David CoxDavid Cox is a freelance journalist focusing on all aspects of health, from fitness and nutrition to infectious diseases and future medicines. Prior to becoming a full-time journalist, he was a neuroscientist attempting to understand how and why the brain goes wrong.
Related Post
November 27, 2025
By Katherine DoylePresident Donald Trump has directed the federal agency that oversees legal immigration to the U.S. conduct a sweeping review of Green Card holders from what the administration calls countries of concern, the head of U.S. Citizenship and Immigration Services said Thursday.“At the direction of @POTUS, I have directed a full scale, rigorous reexamination of every Green Card for every alien from every country of concern,” USCIS Director Joseph Edlow said Thursday afternoon in a statement on X.Edlow said that protecting the country “remains paramount” and that “the American people will not bear the cost of the prior administration’s reckless resettlement policies.”USCIS did not immediately respond to a request for details on which countries are considered “of concern.”The U.S. Citizenship and Immigration Services Miami Field Office.Wilfredo Lee / APThe move comes a day after a shooting near the White House left two members of the National Guard in critical condition. Federal prosecutors say the suspect, an Afghan national who once assisted American forces, was resettled in the U.S. under a program called Operation Allies Welcome during the Biden administration following the U.S. withdrawal from Afghanistan in 2021.Jeanine Pirro, the U.S. Attorney for the District of Columbia, said Thursday morning that her office is reviewing the suspect’s immigration history and the vetting process that allowed his entry into the country.A source familiar with the case and a separate law enforcement source told NBC News that the suspect was granted asylum this year.D.C. National Guard shooting suspect faces charges of assault with intent to kill02:25Two West Virginia National Guard members — identified as Sarah Beckstrom, 20, and Andrew Wolfe, 24, from West Virginia — remain in critical condition following the attack. They were in Washington as part of Trump’s deployment of federal troops to several U.S. cities.In a video released by the White House, Trump called the attack an “act of terror” and said additional National Guard troops would be deployed to Washington.The administration said all immigration requests relating to Afghan nationals will be halted indefinitely.This is a developing story. Please check back for updates.Katherine DoyleKatherine Doyle is a White House reporter for NBC News.
October 14, 2025
World's longest trail of dinosaur footprints uncovered
October 17, 2025
Zelenskyy says he would give the U.S. drones in exchange for Tomahawk missiles
November 5, 2025
UPS Cargo Plane Crashes After Takeoff Leaving at Least 7 Dead
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved